Literature DB >> 2928932

Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides.

K Yoshino1, A Suzuki, Y Mori, H Kakihana, C Honda, Y Mishima, T Kobayashi, K Kanda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2928932

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  25 in total

1.  Tolerance of the normal canine brain to epithermal neutron irradiation in the presence of p-boronophenylalanine.

Authors:  J A Coderre; P R Gavin; J Capala; R Ma; G M Morris; T M Button; T Aziz; N S Peress
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.

Authors:  D D Joel; J A Coderre; P L Micca; M M Nawrocky
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

3.  Implications of radiation microdosimetry for accelerator-based boron neutron capture therapy: a radiobiological perspective.

Authors:  Hisanori Fukunaga; Yusuke Matsuya; Koichi Tokuuye; Motoko Omura
Journal:  Br J Radiol       Date:  2020-05-14       Impact factor: 3.039

4.  Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model.

Authors:  Marcela A Garabalino; Andrea Monti Hughes; Ana J Molinari; Elisa M Heber; Emiliano C C Pozzi; Jorge E Cardoso; Lucas L Colombo; Susana Nievas; David W Nigg; Romina F Aromando; Maria E Itoiz; Verónica A Trivillin; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2010-12-05       Impact factor: 1.925

5.  Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.

Authors:  J A Coderre; E H Elowitz; M Chadha; R Bergland; J Capala; D D Joel; H B Liu; D N Slatkin; A D Chanana
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

6.  Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.

Authors:  W Yang; R F Barth; J H Rotaru; M L Moeschberger; D D Joel; M M Nawrocky; J H Goodman
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

7.  Boron neutron capture therapy: effects of split dose and overall treatment time.

Authors:  G M Morris; P L Micca; M Rezvani; J W Hopewell; J A Coderre
Journal:  J Neurooncol       Date:  2001-04       Impact factor: 4.130

8.  Boron distribution in the normal rat brain after intravenous injection of boronophenylalanine-fructose.

Authors:  Yasushi Shibata
Journal:  J Neurooncol       Date:  2007-11-20       Impact factor: 4.130

Review 9.  Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation.

Authors:  Rolf F Barth; Weilian Yang; Jeffrey A Coderre
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

10.  Pharamacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy: 10B concentration predictions and dosimetric consequences.

Authors:  W S Kiger; M R Palmer; K J Riley; R G Zamenhof; P M Busse
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.